Contextual community epinephrine prescribing: Is more always better?

Area of Science:

• Allergy and Immunology
• Emergency Medicine
• Pharmacology

Background:

• Anaphylaxis affects 1.6% to 5.1% of the population.
• Prompt epinephrine administration is the primary treatment for anaphylaxis.
• Diagnostic criteria are not always met before initiating epinephrine for severe allergic reactions.

Purpose of the Study:

• To review community epinephrine prescribing practices.
• To contextualize the need for multiple epinephrine devices.
• To inform patient-specific management strategies for anaphylaxis.

Main Methods:

• A narrative review of existing literature.
• Analysis of anaphylaxis prevalence and treatment protocols.
• Evaluation of cost-effectiveness for multiple epinephrine device prescriptions.

Main Results:

• A
• 1-2-3
• approach guides anaphylaxis management: prompt first epinephrine dose, followed by consideration of second or third doses with supportive care if needed.
• 90% of anaphylaxis cases resolve with a single epinephrine dose.
• Universal prescription of multiple epinephrine devices is not cost-effective for patients without prior anaphylaxis.

Conclusions:

• Anaphylaxis prevention includes trigger avoidance, symptom recognition, rapid epinephrine administration, and emergency medical services activation.
• Patients with a history of severe reactions requiring multiple epinephrine doses benefit from possessing multiple devices.
• Management should be tailored to individual patient risk and history, avoiding unnecessary multiple device prescriptions.